Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in the Treatment of HER2-positive Early Breast Cancer
Clinical trial NCT06537674 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06537674
- Sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-15
- Primary completion
- 2025-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.